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Abstract
Introduction: Metabolic syndrome involves abdominal obesity, arterial hypertension, type 2 diabetes and lipid disorders manifested as 
atherogenic dyslipidaemia. Abnormal thyroid function affects the severity of MetS components, since regulating metabolism is one of 
the most important functions of thyroid hormones. In this study, we present the influence of hypothyroidism on lipid and carbohydrate 
disorders in patients with MetS.
Material and methods: The described study was a prospective, two-centre screening study of 24-month duration. The study participants 
were 441 patients (350 women, 91 men, aged 28–82) with metabolic syndrome diagnosed according to the 2005 IDF.
Results: By comparing the study and the control group, statistically significant differences were observed in the mean triglyceride levels 
(respectively 161,5 vs. 134,8 mg/dL, p = 0.047), mean fasting glycaemia (respectively 111,8 vs. 126,1 mg/dL, p = 0.044) and TG/HDL ratio 
(4,74 vs. 3,71, p = 0.043).
Hypothyroidism shows a positive correlation with the TG levels and TG/HDL-C ratio and a negative correlation with the mean fasting 
glycaemia in people with MetS. A significantly higher TG/HDL-C ratio and lower mean insulin sensitivity ratio observed in men with 
hypothyroidism, indicated higher insulin resistance in men.
Conclusions: In view of the above, it may be hypothesized that in patients with both MetS and hypothyroidism, especially of male gender, 
the risk of death of cardiovascular causes is greater due to the severity of MetS components.
Moreover, we suggest that in patients recently diagnosed with MetS, active detection of hypothyroidism should be performed by deter-
mining the TSH levels, while patients diagnosed with hypothyroidism (apart from replacement therapy) should be monitored for the 
possible occurrence of MetS in the future. (Endokrynol Pol 2015; 66 (4): 288–294)
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Streszczenie
Wstęp: W skład zespołu metabolicznego wchodzą: otyłość brzuszna, nadciśnienie tętnicze, cukrzyca typu 2 oraz zaburzenia gospodarki 
lipidowej pod postacią aterogennej dyslipidemii. Nieprawidłowa funkcja tarczycy wpływa na poszczególne składowe zespołu metabolic-
znego, z uwagi na różne mechanizmy regulowanie metabolizmu przez hormony tarczycy.
W niniejszym badaniu przedstawiono wpływ niedoczynności tarczycy na zaburzenia gospodarki lipidowej i węglowodanowej u pacjentów 
z rozpoznanym zespołem metabolicznym.
Materiał i metody: Badanie prospektywne, 2-ośrodkowe z grupą badaną obserwowaną przez okres 24 miesięcy. Do badania włączono 
441 pacjentów (350 kobiet oraz 91 mężczyzn w wieku 28–82 lata) z rozpoznanym na podstawie kryteriów IDF zespołem metabolicznym.
Wyniki: Porównując grupę badaną z grupą kontrolną stwierdzono istotne statystycznie różnice w poziomie TG (odpowiednio 161,5 vs. 
134,8 mg/dl, p = 0,047), średnim poziomie glikemii na czczo (odpowiednio 111,8 vs. 126,1 mg/dl, p = 0,044) oraz współczynniku TG/HDL 
(4,74 vs. 3,71, p = 0,043).
Niedoczynność tarczycy występująca u pacjentów z zespołem metabolicznym wykazywała dodatnią korelację ze stężeniem TG oraz 
wskaźnikiem TG/HDL-C oraz ujemną korelację ze średnim poziomem glikemii na czczo. Istotnie wyższy wskaźnik TG/HDL-C, większa 
insulinooporność oraz niższy poziom wskaźnika insulinowrażliwości obserwowano głównie u mężczyzn z niedoczynnością tarczycy. 
Wnioski: W świetle powyższych danych, hipotetycznie można założyć, że u pacjentów z niedoczynnością tarczycy oraz zespołem 
metabolicznym, szczególnie u mężczyzn, ryzyko zgonu z przyczyn sercowo-naczyniowych jest większe w zależności od występowania 
poszczególnych składowych zespołu metabolicznego. 
Autorzy sugerują, aby u wszystkich pacjentów ze stwierdzonym zespołem metabolicznym oznaczyć stężenie TSH w celu wykluczenia 
ewentualnej niedoczynności tarczycy, która pogarsza rokowanie oraz pacjentów z rozpoznaną niedoczynnością tarczycy monitorować 
w kierunku wczesnego rozpoznania zespołu metabolicznego. (Endokrynol Pol 2015; 66 (4): 288–294) 
Słowa kluczowe: zespół metaboliczny; niedoczynność tarczycy; euglikemiczna klamra metaboliczna
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Exclusion criteria:
 — a history of heart surgery or other cardiovascular 
interventions,
 — congenital defects of the heart,
 — cardiac rhythm disorders,
 — pregnancy,
 — chronic kidney disease,
 — electrolyte disorders,
 — inflammation,
 — anaemia,
 — prostate disease,
 — Cushing’s syndrome.
The group was divided into two subgroups: the 
study group with hypothyreosis (n = 177) and control 
group with euthyreosis (n = 264). The diagnosis of hy-
pothyroidism was established on the basis of elevated 
level of TSH and decreased level of fT4 in fasting venous 
blood taken on the day after admission. The hormonal 
profile of the study group is presented in Table II. 
The study protocol was approved by the Ethics 
Committee at the University Hospital in Bydgoszcz. All 
subjects granted their informed consent for participa-
tion in the study.
All statistical analyses were performed using Statistica 
10.0 software (Statsoft Poland, Bydgoszcz). The Mann-
Whitney test, a nonparametric version of the Student’s 
t-test for independent variables, was used for the compari-
Introduction
Metabolic syndrome (MetS) involves abdominal obe-
sity, arterial hypertension, type 2 diabetes, and lipid 
disorders manifested as atherogenic dyslipidaemia 
(hypertriglyceridaemia and hypoHDLaemia) [1, 2]. 
MetS is an important social problem concerning 
a growing number of people. In different countries 
across Europe, its incidence is estimated at 17.4–28% 
[3, 4]; however, in the United States of America about 
24% of males and 23.4% of females are affected [5]. The 
occurrence of metabolic syndrome has increased mainly 
because of abdominal obesity [6].
Abnormal thyroid function affects the severity of 
MetS components, since metabolism regulation is one of 
the most important functions of thyroid hormones [7]. 
In hypothyroidism, the basal metabolism rate is lower, 
the blood lipid profile is disturbed, and body mass and 
insulin resistance are increased [8].
In this study, we present the influence of hypothy-
roidism on lipid and carbohydrate disorders in patients 
with MetS.
Material and methods
The described study was a prospective, two-centre 
(University Hospital No. 1 in Bydgoszcz, District Hospi-
tal in Wąbrzezno, Poland) screening study of 24-month 
duration. The study participants were 441 patients (350 
females [F], 91 males [M], aged 28–82 years) with meta-
bolic syndrome diagnosed according to the 2005 IDF 
(International Diabetes Federation) criteria (meeting at 
least three criteria). The criteria are presented in Table I.
Anthropometric measurements (height, weight, 
and waist circumference) and blood pressure were 
measured in all subjects. Body mass index (BMI) was 
calculated as body weight (in kilograms) divided by the 
square of body height (in metres). Demographic factors 
(age, sex, obesity) were determined.
Fasting total plasma cholesterol (TC), triglycerides 
(TG), high-density-lipoprotein cholesterol (HDL-C), 
and fasting blood glucose (FBG) were determined in all 
patients. Low-density-lipoprotein cholesterol (LDL-C) 
was calculated using the Friedewald formula. Non-
high-density-lipoprotein cholesterol (non-HDL-C) was 
figured on the base of the following formula: TC–HDL-
C. The ratio of triglycerides to HDL-cholesterol (TG/
HDL-C), as an indirect marker of insulin resistance, 
was also evaluated. Insulin resistance was measured 
with the use of a hyperinsulinaemic euglycaemic clamp 
[8], as the gold-standard method. Also the glucose as-
similation ratio (M) — glucose infusion rate adjusted 
accordingly to glucose level changes in time — as an 
insulin resistance was measured. 
Table I. IDF criteria of metabolic syndrome
Tabela I. Kryteria zespołu metabolicznego według IDF
Abdominal obesity [cm] F ≥ 80, M ≥ 94
Arterial hypertension (HT)  
[mm Hg]
≥ 130/85 or treated  
for arterial hypertension
Triglycerides (TG)  
[mg/dL]
≥ 150 [1.7 mmol/L]  
or treated for dyslipidaemia 
HDL-C  
[mg/dL]
< 50 [1.3 mmol/L] in women  
and < 40 [1.0 mmol/L] in men
Fasting glycaemia  
[mg/dL]
≥ 100 [5.6 mmol/L]  
or treated for diabetes
Table II. The hormonal profile of the study group with 
hypothyreosis (mean value ± standard deviation)
Tabela II. Profil hormonalny badanej grupy z niedoczynnością 
tarczycy
TSH  
(0.27–4.2 mIU/L) ± SD
fT4  
(0.93–1.7 ng/dL) ± SD
Female 
n = 140
6.57 ± 1.26 0.68 ± 0.22
Male 
n = 37
6.24 ± 1.72 0.76 ± 0.14
Total 
n = 177
6.48 ± 1.43 0.71 ± 0.20
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son. No parametric tests were used in the analyses because 
for some variables the assumptions of the Student’s t-test 
regarding normal distribution and variance were not met. 
The value of Pearson’s linear correlation coefficient was 
determined in the analysis. The results were considered 
as statistically significant at p < 0.05. The bilateral test 
was used to determine the significance of the differences 
between correlation coefficients. 
Results 
The characteristics of the study and control groups 
(age, sex, waist circumference, and other parameters) 
are presented in Figures 1 and 2.
In the study group, the levels of HDL-C in men 
were higher in a statistically significant manner than in 
women (37.5 vs. 35.3 mg/dL, p = 0.032). The remaining 
MetS parameters did not differ significantly between 
the two groups: mean waist circumference (p = 0.762), 
mean systolic (SYS), and diastolic (DIA) blood pressure 
– (p = 0.102 and p = 0.108), mean triglyceride levels 
(p = 0.183), and mean fasting glycaemia (p = 0.446).
Apart from the MetS components, statistically sig-
nificant differences were observed in body mass (80.2 kg 
in women vs. 95.7 kg in men, p = 0.046) and the mean 
TG/HDL-C ratio (4.42 in women vs. 5.09 in men, 
p = 0.033).
In the control group the levels of HDL-C in men 
were lower in a statistically significant manner than 
in women (34.3 vs. 45.1  mg/dL, p = 0.001), similarly 
to the mean systolic pressure (135.8 vs. 148.8 mm Hg, 
p = 0.013). The remaining MetS parameters did not 
differ significantly between the two groups: mean 
waist circumference (p = 0.908), mean diastolic (DIA) 
blood pressure (p = 0.128), mean triglyceride levels 
(p = 0.098), and mean fasting glycaemia (p = 0.824). 
Apart from the MetS components, statistically sig-
nificant differences were observed in the mean TG/ 
/HDL-C ratio between women and men (3.08 vs. 6.14; 
p = 0.0007) (Fig. 3).
By comparing the study and the control group, 
statistically significant differences were observed in 
the mean triglyceride levels (respectively, 161.5 vs. 134.8 mg/ 
/dL, p = 0.047), mean fasting glycaemia (respectively, 
111.8 vs. 126.1 mg/dL, p = 0.044) and TG/HDL ratio 
(4.74 vs. 3.71, p = 0.043) (Fig. 4).
The distribution of sex in both groups was similar 
(p > 0.05): women made up 79.1% of the members of 
the study group (n = 140) and 79.55% of the members 
of the control group (n = 210). 
By comparing the control and the study groups 
of women, statistically significant differences were 
observed only in the mean triglyceride levels (156.1 vs. 
127.6 mg/dL, p = 0.023) (Fig. 5). 
By comparing the control and the study groups 
of men, no statistically significant differences were 
observed in the above-listed parameters.
Insulin resistance marked by a hyperinsulinaemic 
euglycaemic clamp in both groups is presented in 
Table III. 
Figure 1. Comparison of each parameter according to patient sex in patients with hypothyroidism
Rycina 1. Porównanie poszczególnych parametrów u pacjentów z niedoczynnością tarczycy w zależności od płci
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Discussion
The function of the thyroid affects numerous metabolic 
parameters of the organism, including the metabolism 
of lipoproteins and cardiovascular risk factors (e.g. 
blood pressure, abdominal obesity) [9–12]. The study 
conducted by Roos et al., including 2703 adults, demon-
strated that thyroid function is related to the occurrence 
of metabolic syndrome components. It was observed 
even in subjects classified as being euthyroid, which 
suggests that the effect of thyroid function can be vis-
ible even when its parameters are within the reference 
limits [13]. Lee et al. [14], analysing 7270 euthyroid 
people, described a significant increase in the number 
of components of metabolic syndrome with increasing 
TSH level. 
Figure 2. Comparison of each parameter according to patient sex in patients in euthyreosis
Rycina 2. Porównanie poszczególnych parametrów u pacjentów z prawidłową funkcją tarczycy w zależności od płci
Figure 3. Comparison of MetS indicators in the study and control group
Rycina 3. Porównanie wskaźników zespołu metabolicznego w grupie badanej i grupie kontrolnej
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Table III. Insulin concentration and insulin sensitivity ratio (M) in the study and control group
Tabela III. Stężenie insuliny oraz wskaźnik insulinowrażliwości (M) w grupie badanej i grupie kontrolnej
Sex Study group ± SD Control group ± SD Value P
Insulin  
[U/L]
F 29.88 ± 4.8 25.74 ± 3.4 NS
M 34.67 ± 5.2 26.24 ± 3.9 < 0.05
T 33.22 ± 5.1 26.08 ± 3.7 NS
M  
[µg/kg/min/ins]
F 3.3 ± 0.2 3.5 ± 0.3 NS
M 2.8 ± 0.4 3.8 ± 0.7 < 0.05
T 2.9 ± 0.4 3.7 ± 0.6 NS
Figure 4. Comparison of MetS indicators in both groups of women
Rycina 4. Porównanie wskaźników zespołu metabolicznego w grupie badanej i grupie kontrolnej u kobiet
Figure 5. Comparison of MetS indicators in both groups of men
Rycina 5. Porównanie wskaźników zespołu metabolicznego w grupie badanej i grupie kontrolnej u mężczyzn
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Hypothyroidism is accompanied by increased in-
sulin resistance, which is considered as the principal 
disorder and potential basis for the development of 
metabolic syndrome. Fernandez et al. and Roos et al. 
[13, 15] indicated that the TSH levels are related to in-
sulin resistance. It was demonstrated that the activity 
of thyroid hormones affects the expression of factors 
regulating tissue sensitivity to insulin, including the 
β-2 adrenergic receptors and peroxisome proliferator-
activated receptors (PPAR-γ) [16, 17]. This correlation 
even occurs when thyroid function is within physi-
ological limits and thyroid disorders may decrease tis-
sue sensitivity to insulin [17, 18]. 
On the other hand, a hypothesis indicating the role 
of MetS components in the development of thyroid 
disorders has also been proposed [17]. Chronic inflam-
mation is considered responsible for this phenomenon, 
since increased levels of inflammatory cytokines, such 
as Il-6 or TNF-α, were observed in obese people with 
MetS [19]. Also, a study conducted by Shantha et al. 
demonstrated that patients with MetS and subclinical 
hypothyroidism have significantly higher levels of an 
inflammation marker (hs CRP) [20], which may inhibit 
thyroid function by acting directly on this gland or via 
the hypothalamic pituitary axis [18].
The results of our study also confirm the relation 
between thyroid function and components of MetS. 
The positive correlation between TSH and serum lipid 
concentration (TC, TG, LDL-C) was observed in many 
studies published previously [21]. In the Health ABC 
study TG levels were positively related to overt and 
subclinical hypothyroidism. Also in our study the mean 
TG levels were increased in the study group compared 
to the control group (161.5 mg/dL vs. 134.8  mg/dL, 
p = 0.047) as well as in females as in males (156.1 vs. 
127.6 mg/dL and 191.1 vs. 162.6 mg/dL, respectively). 
The mean TG/HDL-C ratio, which is thought to be 
a substitute marker of insulin resistance [16], was also 
increased in the study group compared to the control 
group (4.74 vs. 3.71; p = 0.043). Thus, the group with 
hypothyroidism, in comparison to the control group, 
may demonstrate higher insulin resistance and conse-
quently higher risk of development of cardio-vascular 
diseases.
It is worth noticing that in both the study and the 
control group, the mean TG/HDL ratio was significantly 
higher in men than in women (5.09 vs. 4.42; p = 0.033 
and 4.74 vs. 3.08; p = 0.0007, respectively), which can 
demonstrate higher insulin resistance. Hadaegh et 
al. [16] found that female gender had lower risk for 
incident of MetS than male [HR: 0.58 (0.47-0.70)]. Also, 
Cheserek et al. [22] showed that subclinical hypo-
thyroidism was associated with metabolic syndrome 
components in males but not in females.
A statistically significant difference was also observed 
by means of hyperinsulinaemic euglycaemic clamp in 
men with MetS and hypothyroidism in comparison 
to those without thyroid disorders. The mean insulin 
sensitivity ratio (M) was significantly lower in men from 
the study group compared to the control group. In the 
group of women similar results were not obtained. 
Interestingly, a statistically significant difference was 
also observed in the mean fasting glycaemia, which 
was lower in the study group with hypothyreosis. The 
results are in opposition to those published earlier. 
The previous studies revealed a positive correlation of 
hypothyroidism with elevated fasting glucose levels. 
Conclusions
Hypothyroidism shows a positive correlation with TG 
levels and TG/HDL-C ratio and a negative correlation 
with mean fasting glycaemia in people with MetS. The 
significantly higher TG/HDL-C ratio and lower mean 
insulin sensitivity ratio observed in men with hypo-
thyroidism indicated higher insulin resistance in men. 
In view of the above, it may be hypothesised that in 
patients with both MetS and hypothyroidism, especially 
of male gender, the risk of death from cardiovascular 
causes is greater due to the severity of MetS components. 
Moreover, we suggest that in patients recently diag-
nosed with MetS, active detection of hypothyroidism 
should be performed by determining the TSH levels, 
while patients diagnosed with hypothyroidism (apart 
from replacement therapy) should be monitored for the 
possible occurrence of MetS in the future.
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